Stanabol 10 mg is an oral stanozolol tablet manufactured by British Dragon and dosed at 10 mg per tablet, supplied in packs of 100 tablets.
Stanabol 10 mg contains stanozolol, a synthetic oral anabolic-androgenic steroid derived from dihydrotestosterone. Stanozolol was originally developed in the 1960s and is FDA-approved for the treatment of hereditary angioedema, a condition characterized by recurrent episodes of severe swelling . The recommended initial dose for this indication is 2 mg three times daily, with maintenance doses of 2 mg once daily to once every three days .
Stanozolol is a 17α-alkylated steroid, which allows it to survive first-pass metabolism in the liver but also contributes to its hepatotoxicity. The compound is not aromatized to estrogen, so it does not cause gynecomastia or water retention . It has strong anabolic activity with relatively low androgenic activity, and it does not convert to estrogen, making it popular for cutting phases where maintaining muscle while reducing body fat is the goal .
In non-medical bodybuilding contexts, stanozolol is commonly referenced for its ability to promote lean, hard muscle and enhance vascularity. It is often used during cutting cycles and is popular among athletes for strength and speed without significant weight gain . However, the compound carries significant risks including hepatotoxicity, adverse lipid changes, and androgenic side effects. It is prohibited by WADA at all times under S1.1 Anabolic Androgenic Steroids. Such use falls outside approved indications.
Stanozolol is a 17α-alkylated oral anabolic steroid with strong anabolic and relatively low androgenic activity, FDA-approved for hereditary angioedema .
Stanozolol is a synthetic derivative of dihydrotestosterone (DHT) modified with a 17α-methyl group and a pyrazole ring. These modifications confer oral bioavailability and resistance to hepatic metabolism, but also contribute to its hepatotoxicity. The compound is not aromatized to estrogen, so it does not cause water retention or gynecomastia .
Stanozolol binds to androgen receptors in muscle tissue, promoting protein synthesis and nitrogen retention. It is FDA-approved for hereditary angioedema, a condition characterized by recurrent episodes of severe swelling . The recommended initial dose is 2 mg three times daily, with maintenance doses of 2 mg once daily to once every three days .
In non-medical bodybuilding contexts, stanozolol is commonly referenced for cutting phases due to its ability to promote lean, hard muscle without water retention. It is often stacked with injectable compounds such as Testabol Propionate or Trenabol 100 during cutting cycles.
Stanozolol is FDA-approved for hereditary angioedema . Products marketed for research purposes are not approved for human use, and non-medical use falls outside approved indications.
British Dragon offers several oral compounds with distinct characteristics. Oxanabol contains oxandrolone, a milder oral with a more favorable safety profile. Methanabol contains methandienone, a more potent bulking oral that aromatizes to estrogen. Stanabol Inj contains stanozolol in an injectable form (Winstrol Depot).
Stanabol 10's distinguishing characteristic among these compounds is its non-aromatizing nature and its strong anabolic activity, making it a commonly referenced option for cutting phases or for users seeking lean mass preservation without water retention.
Published laboratory reports for Stanabol 10 mg are shown below with the test date, measured result and percentage of the product's 10 mg label claim.
View Report
Laboratory results apply to the specific tested sample represented in each published report and should not be interpreted as a measurement of every tablet or production batch.
The information below is provided for educational reference only. Stanozolol is a prescription medication; medical use requires appropriate diagnosis, clinical supervision, and ongoing monitoring. Non-medical use falls outside approved indications.
In clinical practice for hereditary angioedema, the recommended initial dose is 2 mg three times daily, with maintenance doses of 2 mg once daily to once every three days . In non-medical bodybuilding contexts, stanozolol is commonly referenced at 20 to 50 mg daily, though such use falls outside approved indications and carries substantial risks.
| Use Case | Common Reference Range | Frequency |
|---|---|---|
| Clinical (hereditary angioedema, initial) | 2 mg | Three times daily |
| Clinical (maintenance) | 2 mg | Once daily to once every 3 days |
| Non-medical (cutting, reported) | 20–50 mg | Daily, divided doses |
These non-medical ranges represent community-reported practices and are not derived from controlled clinical trials for performance enhancement. Cycle duration is typically limited to 6–8 weeks due to hepatotoxicity concerns.
In non-medical bodybuilding contexts, stanozolol is frequently referenced in cutting cycles, where its non-aromatizing nature and ability to promote lean, hard muscle are valued. It is often stacked with injectable compounds such as Testabol Propionate or Trenabol 100 during cutting phases.
Because stanozolol does not aromatize, it does not require aromatase inhibitors for estrogen management. However, it can suppress endogenous testosterone production, so post-cycle therapy may be referenced after use.
Stanozolol carries significant risks. Hepatotoxicity is a primary concern, as the 17α-alkylated structure is associated with cholestatic jaundice and elevated liver enzymes. Adverse lipid changes include decreased HDL cholesterol and increased LDL cholesterol, which may impact cardiovascular risk.
Other potential effects include suppression of endogenous testosterone production, which may lead to testicular atrophy and reduced fertility. Women may experience virilization including deepening of the voice and clitoral enlargement. Androgenic side effects such as acne and hair loss may occur in predisposed individuals.
Stanozolol suppresses endogenous testosterone production, requiring post-cycle therapy to restore natural hormone levels. In non-medical contexts, PCT protocols typically involve SERMs such as Clomiphene or Tamoxifen, beginning after the compound has cleared the system.
Stanozolol has approved dosing for specific medical indications. Any information about non-medical use is derived from user-reported practices and is not validated by controlled clinical research. This information does not constitute medical advice.
Stanozolol is a prescription anabolic steroid with significant hepatotoxicity and cardiovascular risks. It is not approved for human use in the United States for performance purposes.
Stanozolol is a 17α-alkylated anabolic steroid, a structural class associated with significant hepatotoxicity. The FDA label includes a boxed warning for peliosis hepatitis, a condition in which liver and sometimes splenic tissue is replaced with blood-filled cysts. These cysts are sometimes present with minimal hepatic dysfunction but have been associated with liver failure and intra-abdominal hemorrhage .
Stanozolol is contraindicated in pregnancy (Category X), known or suspected carcinoma of the prostate or male breast, carcinoma of the breast in females with hypercalcemia, nephrosis, and severe hepatic dysfunction .
Non-medical use of stanozolol falls outside approved indications. Product purity does not establish that non-medical use is safe or appropriate for an individual.
Boxed warnings include liver cell tumors (most often benign and androgen-dependent, but fatal malignant tumors have been reported) and blood lipid changes including decreased HDL and sometimes increased LDL, which may have a serious impact on atherosclerosis and coronary artery disease risk .
Other adverse effects include virilization in women (deepening of voice, hirsutism, acne, clitoral enlargement, menstrual irregularities) which may be irreversible, and premature closure of epiphyses in children . Suppression of endogenous testosterone production may lead to testicular atrophy and reduced fertility.
Stanozolol is not appropriate for everyone. Contraindications include pregnancy, prostate cancer, male breast cancer, nephrosis, and severe hepatic dysfunction . Caution is advised in patients with cardiovascular disease, diabetes, or edema .
Geriatric patients treated with androgens may be at increased risk of developing prostatic hypertrophy .
Clinical monitoring recommendations include periodic liver function tests, serum lipids, and hemoglobin/hematocrit. Patients should report signs of liver problems including dark urine, tiredness, decreased appetite, upset stomach, stomach pain, vomiting, or yellowing of the skin or eyes.
Store tablets in a cool, dry place in the original packaging. Keep out of reach of children. Inspect tablets before use and do not use if they appear damaged or compromised.
Stanabol 10 mg is supplied through the official British Dragon distribution chain and shipped in original manufacturer packaging with discreet, privacy-focused handling.
The outer shipping package remains discreet, with privacy-focused handling and no unnecessary external product details. Products are supplied through the official British Dragon distribution chain.
To verify your Stanabol 10 mg product, use the security code on the packaging and cross-check it on the British Dragon official site. Official British Dragon presentation and original packaging help reinforce product legitimacy and buyer confidence.
For complete delivery details, tracking policy, and reshipment terms, please see our Shipping Info page.
Proper storage conditions help preserve tablet stability and overall product integrity throughout shelf life.
Store at controlled room temperature (15–25°C) in a cool, dry place, away from direct light and moisture. Keep tablets in their original packaging until use to protect from humidity.
Inspect tablets before use and do not use if they appear discolored, cracked, or otherwise compromised. Keep out of reach of children.
Answers to common questions about Stanabol 10 mg, the Stanozolol compound, and its applications.
Stanabol 10 mg contains stanozolol, an oral anabolic steroid. In clinical medicine, it is approved for hereditary angioedema . In non-medical bodybuilding contexts, it is commonly referenced for cutting phases and lean muscle preservation, though such use falls outside approved indications.
Clinical dosing for hereditary angioedema starts at 2 mg three times daily, with maintenance of 2 mg once daily to once every three days . In non-medical contexts, stanozolol is commonly referenced at 20–50 mg daily. These non-medical practices are not derived from controlled clinical trials for performance enhancement.
Yes, stanozolol suppresses endogenous testosterone production, requiring post-cycle therapy to restore natural hormone levels. In non-medical contexts, PCT protocols typically involve SERMs such as Clomiphene or Tamoxifen.
Stanozolol binds to androgen receptors in muscle tissue, promoting protein synthesis and nitrogen retention. It is not aromatized to estrogen, so it does not cause water retention or gynecomastia . It has strong anabolic activity with relatively low androgenic activity.
In non-medical contexts, users commonly report effects on strength and lean mass beginning within 2–4 weeks of use, though individual response varies. Cycle duration is typically limited to 6–8 weeks due to hepatotoxicity concerns.
There is no universally established "best" oral steroid, and stanozolol has not been validated in controlled trials for performance outcomes. Its non-aromatizing nature and ability to promote lean, hard muscle make it a commonly referenced option, but its hepatotoxicity is a significant drawback.
Stanabol and Oxanabol are both oral steroids that do not aromatize, but they differ in other ways. Stanozolol has stronger anabolic activity but carries higher liver toxicity, while oxandrolone has a more favorable safety profile. They are used for similar purposes but have different risk profiles.
Stanabol and Methanabol have different characteristics. Stanozolol does not aromatize and is commonly referenced for cutting, while methandienone is a more potent bulking compound that aromatizes to estrogen. They are used for different purposes in non-medical contexts.
Stanabol 10 mg is labeled at 10 mg of stanozolol per tablet. This is within the clinical range for hereditary angioedema (2 mg three times daily) . In non-medical contexts, 10 mg is often considered a low dose, with 20–50 mg daily commonly referenced for performance purposes.
Stanabol 10 mg is labeled at 10 mg of stanozolol per tablet. It is supplied as oral tablets in packs of 100 tablets manufactured by British Dragon.
Yes. A published laboratory report dated March 23, 2026 measured Stanabol 10 mg at 9.03 mg, equivalent to 90.30% of its 10 mg label claim. The complete report can be viewed in the Lab Reports tab.